Ad26.cov2-s/albumin-humanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1929卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25640-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[11] Ad26.cov2-s/elasomeran/tozinameranSensorineural Hearing Loss: case report
Reactions Weekly, 2022, 1906 (1) : 20 - 20
[12] Ad26.COV2-S/omalizumabIdiopathic bradykinin-mediated angioedema and lack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 19 - 19
[13] Ad26.COV2-S/RituximabProtracted COVID 19, plasma cell depletion and lack of efficacy : case report
Reactions Weekly, 2022, 1917 (1) : 24 - 24
[14] Ad26.cov2-s/elasomeranDemyelinating neuropathy: 2 case reports
Reactions Weekly, 2022, 1917 (1) : 22 - 22
[15] Ad26.cov2-s/tozinameranMyocarditis: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 22 - 22
[16] Ad26.cov2-s/tozinameranGuttate psoriasis: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 25 - 25
[17] Ad26.cov2-s/immune-globulinChronic inflammatory demyelinating polyradiculoneuropathy and lack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 20 - 20
[18] Ad26.cov2-s/prednisoneFocal segmental glomerulosclerosis and no therapeutic response: case report
Reactions Weekly, 2022, 1936 (1) : 19 - 19
[19] Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports
Reactions Weekly, 2022, 1917 (1) : 23 - 24
[20] Ad26.cov2-s/immune-globulinGuillain barre syndrome and pseudohyponatraemia: case report
Reactions Weekly, 2022, 1893 (1) : 17 - 17

← 1 2 3 4 5 →